JAZZ · Forms 3, 4, 5
Insider trades at Jazz Pharmaceuticals plc
2 insiders sold $1.9M of Jazz Pharmaceuticals plc stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for Jazz Pharmaceuticals plc (JAZZ) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Renee D Gala | President & CEO | Sell | 2,000 | $236.40 | $473K | Form 4 | |
| Bruce C Cozadd | Director | Sell | 6,000 | $230.33 | $1.4M | Form 4 | |
| Neena M Patil | EVP & Chief Legal Officer | Sell | 1,200 | $240.94 | $289K | Form 4 | |
| Renee D Gala | President & CEO | Tax withholding | 1,967 | $246.81 | $485K | Form 4 | |
| Renee D Gala | President & CEO | Sell | 2,000 | $243.03 | $486K | Form 4 | |
| Mary Elizabeth Henderson | SVP, Technical Operations | Tax withholding | 1,412 | $243.03 | $343K | Form 4 | |
| Mary Elizabeth Henderson | SVP, Technical Operations | Tax withholding | 15 | $241.20 | $4K | Form 4 | |
| Bruce C Cozadd | Director | Sell | 6,000 | $250.13 | $1.5M | Form 4 | |
| Mary Elizabeth Henderson | SVP, Technical Operations | Tax withholding | 2,076 | $241.39 | $501K | Form 4 | |
| Mary Elizabeth Henderson | SVP, Technical Operations | Tax withholding | 16 | $244.64 | $4K | Form 4 | |
| Mark Douglas Smith | Director | Tax withholding | 14 | $244.64 | $3K | Form 4 | |
| Mark Douglas Smith | Director | Tax withholding | 1,692 | $241.39 | $408K | Form 4 | |
| Norbert G Riedel | Director | Tax withholding | 14 | $244.64 | $3K | Form 4 | |
| Norbert G Riedel | Director | Tax withholding | 1,692 | $241.39 | $408K | Form 4 | |
| Ted W Love | Director | Tax withholding | 6 | $244.06 | $1K | Form 4 | |
| Ted W Love | Director | Tax withholding | 737 | $241.39 | $178K | Form 4 | |
| Laura Hamill | Director | Tax withholding | 14 | $244.06 | $3K | Form 4 | |
| Laura Hamill | Director | Tax withholding | 1,692 | $241.39 | $408K | Form 4 | |
| Jennifer E. Cook | Director | Tax withholding | 14 | $244.06 | $3K | Form 4 | |
| Jennifer E. Cook | Director | Tax withholding | 1,692 | $241.39 | $408K | Form 4 | |
| Patrick G Enright | Director | Tax withholding | 14 | $244.64 | $3K | Form 4 | |
| Patrick G Enright | Director | Tax withholding | 1,692 | $241.39 | $408K | Form 4 | |
| Heather Ann McSharry | Director | Tax withholding | 15 | $244.64 | $4K | Form 4 | |
| Heather Ann McSharry | Director | Tax withholding | 1,840 | $241.39 | $444K | Form 4 | |
| Patrick Kennedy | Director | Tax withholding | 15 | $244.06 | $4K | Form 4 | |
| Patrick Kennedy | Director | Tax withholding | 1,840 | $241.39 | $444K | Form 4 | |
| Rick E Winningham | Director | Tax withholding | 1,692 | $241.39 | $408K | Form 4 | |
| Rick E Winningham | Director | Tax withholding | 14 | $244.64 | $3K | Form 4 | |
| Bruce C Cozadd | Director | Tax withholding | 10 | $244.06 | $2K | Form 4 | |
| Bruce C Cozadd | Director | Tax withholding | 1,209 | $241.39 | $292K | Form 4 | |
| Robert Iannone | EVP, Global Head of R&D & CMO | Option exercise | 26,116 | $113.10 | $3M | Form 4 | |
| Robert Iannone | EVP, Global Head of R&D & CMO | Option exercise | 884 | $113.10 | $100K | Form 4 | |
| Robert Iannone | EVP, Global Head of R&D & CMO | Option exercise | 27,584 | $137.12 | $3.8M | Form 4 | |
| Robert Iannone | EVP, Global Head of R&D & CMO | Option exercise | 2,916 | $137.12 | $400K | Form 4 | |
| Robert Iannone | EVP, Global Head of R&D & CMO | Sell | 18,187 | $247.86 | $4.5M | Form 4 | |
| Robert Iannone | EVP, Global Head of R&D & CMO | Sell | 11,423 | $248.67 | $2.8M | Form 4 | |
| Robert Iannone | EVP, Global Head of R&D & CMO | Sell | 18,113 | $250.02 | $4.5M | Form 4 | |
| Robert Iannone | EVP, Global Head of R&D & CMO | Sell | 19,639 | $250.60 | $4.9M | Form 4 | |
| Robert Iannone | EVP, Global Head of R&D & CMO | Sell | 9,259 | $251.95 | $2.3M | Form 4 | |
| Robert Iannone | EVP, Global Head of R&D & CMO | Sell | 300 | $252.76 | $76K | Form 4 | |
| Samantha Pearce | EVP, Chief Commercial Officer | Tax withholding | 780 | $261.62 | $204K | Form 4 | |
| Rick E Winningham | Director | Award | 1,605 | Form 4 | |||
| Ted W Love | Director | Award | 1,605 | Form 4 | |||
| Laura Hamill | Director | Award | 1,605 | Form 4 | |||
| Patrick Kennedy | Director | Award | 1,605 | Form 4 | |||
| Mark Douglas Smith | Director | Award | 1,605 | Form 4 | |||
| Jennifer E. Cook | Director | Award | 1,605 | Form 4 | |||
| Seamus Mulligan | Director | Award | 1,605 | Form 4 | |||
| Heather Ann McSharry | Director | Award | 1,605 | Form 4 | |||
| Patrick G Enright | Director | Award | 1,605 | Form 4 | |||
| Norbert G Riedel | Director | Award | 1,605 | Form 4 | |||
| Bruce C Cozadd | Director | Award | 1,605 | Form 4 | |||
| Bruce C Cozadd | Director | Sell | 6,000 | $252.98 | $1.5M | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.